| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4785130
Max Phase: Preclinical
Molecular Formula: C16H14F3N2O3P
Molecular Weight: 370.27
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCP(=O)(OC)c1ccc2oc(-c3cccnc3C(F)(F)F)nc2c1
Standard InChI: InChI=1S/C16H14F3N2O3P/c1-3-25(22,23-2)10-6-7-13-12(9-10)21-15(24-13)11-5-4-8-20-14(11)16(17,18)19/h4-9H,3H2,1-2H3
Standard InChI Key: KBIIESRQDBPGLI-UHFFFAOYSA-N
Associated Targets(Human)
UTRN Tchem Utrophin (89 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 370.27 | Molecular Weight (Monoisotopic): 370.0694 | AlogP: 4.48 | #Rotatable Bonds: 4 |
| Polar Surface Area: 65.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 1.12 | CX LogP: 3.42 | CX LogD: 3.42 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.63 | Np Likeness Score: -1.06 |
References
| 1. Chatzopoulou M,Emer E,Lecci C,Rowley JA,Casagrande AS,Moir L,Squire SE,Davies SG,Harriman S,Wynne GM,Wilson FX,Davies KE,Russell AJ. (2020) Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators., 11 (12): [PMID:33335663] [10.1021/acsmedchemlett.0c00405] |
Source
Source(1):